Common Name |
Bromfenac
Description |
Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocliar pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool to optimize surgical outcomes.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
2-amino-3-(4-Bromobenzoyl)benzeneacetic acidChEBI
[2-amino-3-(4-bromo-Benzoyl)-phenyl]-acetic acidChEBI
BromfenacoChEBI
BromfenacumChEBI
2-amino-3-(4-Bromobenzoyl)benzeneacetateGenerator
[2-amino-3-(4-bromo-Benzoyl)-phenyl]-acetateGenerator
Bromfenac sodiumHMDB
XibromMeSH
Sodium bromfenacMeSH
Wyeth brand OF sodium bromfenacMeSH
DuractMeSH
Chemical Formlia |
C15H12BrNO3
Average Molecliar Weight |
334.165
Monoisotopic Molecliar Weight |
333.000055902
IUPAC Name |
2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
Traditional Name |
bromfenac
CAS Registry Number |
91714-94-2
SMILES |
NC1=C(CC(O)=O)C=CC=C1C(=O)C1=CC=C(Br)C=C1
InChI Identifier |
InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
InChI Key |
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of organic compounds known as benzophenones. These are organic compounds containing a ketone attached to two phenyl groups.
Kingdom |
Organic compounds
Super Class |
Benzenoids
Class |
Benzene and substituted derivatives
Sub Class |
Benzophenones
Direct Parent |
Benzophenones
Alternative Parents |
Diphenylmethanes
Aryl-phenylketones
Benzoyl derivatives
Aniline and substituted anilines
Bromobenzenes
Aryl bromides
Vinylogous amides
Amino acids
Monocarboxylic acids and derivatives
Carboxylic acids
Primary amines
Organopnictogen compounds
Organobromides
Organic oxides
Hydrocarbon derivatives
Substituents |
Benzophenone
Diphenylmethane
Aryl-phenylketone
Benzoyl
Aryl ketone
Aniline or substituted anilines
Bromobenzene
Halobenzene
Aryl bromide
Aryl halide
Vinylogous amide
Amino acid
Amino acid or derivatives
Ketone
Carboxylic acid derivative
Carboxylic acid
Monocarboxylic acid or derivatives
Hydrocarbon derivative
Organohalogen compound
Organopnictogen compound
Organobromide
Organonitrogen compound
Carbonyl group
Amine
Organic oxygen compound
Organic nitrogen compound
Organooxygen compound
Primary amine
Organic oxide
Aromatic homomonocyclic compound
Molecliar Framework |
Aromatic homomonocyclic compounds
External Descriptors |
organobromine compound (CHEBI:240107 )
benzophenones (CHEBI:240107 )
substituted aniline (CHEBI:240107 )
aromatic amino acid (CHEBI:240107 )
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Analgesics
Application |
Pharmaceutical
Cellliar locations |
Cytoplasm
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility1.26e-02 g/LNot Available
LogP3.4Not Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.013 mg/mLALOGPS
logP3ALOGPS
logP3.66ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)3.81ChemAxon
pKa (Strongest Basic)1.59ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area80.39 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity80.26 m3·mol-1ChemAxon
Polarizability29.93 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Spectrum Type |
Description |
Splash Key |
|
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available
Predicted LC-MS/MS |
Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available
Biological Properties |
Cellliar Locations |
Cytoplasm
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Name |
SMPDB Link |
KEGG Link |
Bromfenac PathwaySMP00102Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB00963
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB00963
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB00963
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
54730
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Not Available
NuGOwiki Link |
HMDB15098
Metagene Link |
HMDB15098
METLIN ID |
Not Available
PubChem Compound |
60726
PDB ID |
Not Available
ChEBI ID |
240107
Product: Berberine (chloride hydrate)
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
Enzymes
- General function:
- Involved in peroxidase activity
- Specific function:
- Mediates the formation of prostaglandins from arachidonate. May have a role as a major mediator of inflammation and/or a role for prostanoid signaling in activity-dependent plasticity.
- Gene Name:
- PTGS2
- Uniprot ID:
- P35354
- Molecular weight:
- 68995.625
References
- Waterbury LD, Silliman D, Jolas T: Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006 Jun;22(6):1133-40. [PubMed:16846546 ]
- Sanchez-Matienzo D, Arana A, Castellsague J, Perez-Gutthann S: Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. Clin Ther. 2006 Aug;28(8):1123-32. [PubMed:16982289 ]
- Chitturi S, George J: Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis. 2002;22(2):169-83. [PubMed:12016548 ]
- Cho H, Wolf KJ, Wolf EJ: Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol. 2009;3:199-210. Epub 2009 Jun 2. [PubMed:19668566 ]
- General function:
- Involved in peroxidase activity
- Specific function:
- May play an important role in regulating or promoting cell proliferation in some normal and neoplastically transformed cells.
- Gene Name:
- PTGS1
- Uniprot ID:
- P23219
- Molecular weight:
- 68685.82
References
- Waterbury LD, Silliman D, Jolas T: Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. Curr Med Res Opin. 2006 Jun;22(6):1133-40. [PubMed:16846546 ]
- Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
PMID: 27738012